Ignite Creation Date:
2025-12-24 @ 4:05 PM
Ignite Modification Date:
2025-12-27 @ 8:01 AM
Study NCT ID:
NCT00886366
Status:
TERMINATED
Last Update Posted:
2010-12-07
First Post:
2009-04-17
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Single Ascending Dose Study With Healthy Male Volunteers and Type II Diabetic Patients
Sponsor:
AstraZeneca
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
D1920C00001
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
Klas Malmberg, MD, PhD, Prof. Medical Science Director
Old Organization:
AstraZeneca Pharmaceuticals